What Is GLP-1? The Peptide Hormone Behind Ozempic, Wegovy and Mounjaro

Like our Content? Stay connected via Google

Follow us for the latest health and wellness information.

If you have spent any time reading health news in the last couple of years, you have almost certainly come across the letters GLP-1. These three letters have become shorthand for a class of medications that changed the conversation about weight management overnight. But GLP-1 is not a drug. It is a peptide hormone your body already makes, and understanding what it does can help you make better decisions about your health whether you ever take a medication or not.

What Is GLP-1?

I have spent more than 25 years in health and fitness, and I have watched trends come and go. GLP-1 is not a trend. The science behind this peptide hormone is some of the most rigorously studied in modern endocrinology, and it has implications for everything from blood sugar regulation to heart health. In this guide, I am going to break down exactly what GLP-1 is, how it works, what the medications do, and how you can support your body's own GLP-1 production through food and lifestyle.

GLP-1 stands for glucagon-like peptide-1. The name tells you exactly what it is: a peptide (a short chain of amino acids) that is structurally similar to the hormone glucagon. Specifically, GLP-1 is a peptide hormone, meaning it is a signaling molecule made of amino acids that travels through your bloodstream to deliver messages to distant organs and tissues. It is an incretin hormone produced primarily by L-cells in the lining of your small intestine and colon in response to eating. When you consume a meal, especially one containing protein, fiber, and healthy fats, these L-cells release GLP-1 into your bloodstream.

Disclaimer: Links may contain affiliate links, which means we may get paid a commission at no additional cost to you if you purchase through this page. Read our full disclosure here.

The “glucagon-like” part of the name comes from GLP-1's origin. It is derived from the same precursor gene (preproglucagon) as the hormone glucagon, but it is processed differently in intestinal L-cells than in pancreatic alpha cells, producing a distinct peptide with very different effects. While glucagon raises blood sugar, GLP-1 helps lower it. The word “incretin” refers to a group of gut peptide hormones that enhance the insulin response after you eat. The incretin effect was first described in the 1960s when researchers noticed that oral glucose triggered two to three times more insulin secretion than the same amount of glucose given intravenously. Something in the gut was amplifying the signal, and that something turned out to be incretin hormones, primarily GLP-1 and its partner GIP (glucose-dependent insulinotropic polypeptide).

Here is the key thing to understand: your body already makes GLP-1 every time you eat. The medications that have gotten so much attention are synthetic peptide analogs designed to mimic and amplify what your body does naturally, but at much higher and more sustained levels than your gut produces on its own. They are engineered to resist the DPP-4 enzyme that normally breaks down natural GLP-1 within minutes.

How GLP-1 Works in Your Body

Natural GLP-1 has a remarkably short lifespan. Once released, it lasts only about one to two minutes in your bloodstream before an enzyme called DPP-4 (dipeptidyl peptidase-4) breaks it down. Despite that brief window, GLP-1 sets off a cascade of effects across multiple organ systems.

In Your Pancreas

GLP-1 stimulates your pancreatic beta cells to release insulin, but only when blood sugar is elevated. This glucose-dependent mechanism is critical because it means GLP-1 does not cause dangerous drops in blood sugar the way some older diabetes medications can. At the same time, GLP-1 suppresses glucagon production from alpha cells when blood sugar is high, which further helps bring glucose levels down after a meal.

In Your Stomach

GLP-1 slows gastric emptying, meaning food stays in your stomach longer. This is one of the main reasons people on GLP-1 medications feel full faster and stay full longer. It also contributes to some of the most common side effects like nausea, which I will cover later.

In Your Brain

GLP-1 receptors are found throughout the brain, particularly in areas that regulate appetite and reward. GLP-1 acts on neurons in the brain's satiety center, reducing hunger signals and diminishing the reward value of food. This is why many people on GLP-1 medications describe a fundamental shift in their relationship with food. The “food noise” quiets down.

GLP-1 and Weight Management

The weight loss effects of GLP-1 receptor agonists are well documented. In the landmark SELECT trial, semaglutide 2.4 mg demonstrated a 20% relative risk reduction in major adverse cardiovascular events in over 17,000 patients with obesity but without diabetes. The SURMOUNT trials with tirzepatide showed even more dramatic weight loss results.

But here is what I want you to understand: weight loss on GLP-1 medications is not just fat loss. The STEP 1 clinical trial showed that participants on semaglutide lost both fat mass and lean mass during treatment. This is a critical issue, especially for women over 40 who are already dealing with age-related muscle loss. I have written extensively about this in my guide to protecting lean mass on GLP-1 medications, because losing muscle is the single biggest risk of unsupported weight loss at any age.

The solution is not to avoid GLP-1 medications if you and your doctor decide they are right for you. The solution is to pair them with the right nutrition and exercise strategy. That means prioritizing protein intake (1.2 to 1.6 grams per kilogram of body weight at minimum, optimal for muscle protection is about 2.2 grams per kilogram or 1 gram per pound of ideal body weight) and doing consistent resistance training. If you are on a GLP-1 medication or considering one, my GLP-1 diet plan is a good place to start building that foundation.

GLP-1 Medications: Semaglutide, Tirzepatide, and Beyond

The development of GLP-1 receptor agonists has progressed through three generations of increasingly effective medications. Understanding the landscape helps you have informed conversations with your healthcare provider.

Semaglutide (Ozempic, Wegovy, Rybelsus)

Semaglutide is a GLP-1 receptor agonist, meaning it activates only the GLP-1 receptor. It is the active ingredient in several brand name drugs: Ozempic (approved for type 2 diabetes), Wegovy (approved for weight management as both injection and pill), and Rybelsus (an oral formulation for diabetes). Despite having the same active molecule, these medications differ in dosing, indication, and insurance coverage. I break down the specifics in my Wegovy vs Ozempic comparison.

In December 2025, the FDA approved the Wegovy pill, making it the first oral GLP-1 medication approved specifically for weight loss. The pill uses the same semaglutide molecule at a higher oral dose (up to 25 mg daily) and produced comparable weight loss to the injection in the OASIS 4 trial: 16.6 percent average body weight reduction when participants adhered to treatment over 64 weeks. For women over 40, the menopause subgroup data is particularly relevant, showing significant weight loss across pre-menopausal (18.2 percent), peri-menopausal (15.0 percent), and post-menopausal (15.7 percent) women. For a complete breakdown of how the pill works, dosing, cost and who is eligible, read my full Wegovy pill guide.

Tirzepatide (Mounjaro, Zepbound)

Tirzepatide is a dual GIP/GLP-1 receptor agonist, meaning it activates both incretin pathways simultaneously. Clinical trials have shown tirzepatide provides superior glycemic control and weight loss compared to GLP-1 receptor agonists alone, likely due to synergistic effects between the two incretin systems. Mounjaro is approved for diabetes and Zepbound for weight management. For a detailed comparison, see my tirzepatide vs semaglutide breakdown.

Next Generation Medications

The GLP-1 landscape is evolving rapidly. Two pipeline drugs are particularly worth watching. CagriSema is Novo Nordisk's next-generation combination of semaglutide with cagrilintide, an amylin analog. Early data suggests even greater weight loss than semaglutide alone, and an FDA decision is expected in 2026. Orforglipron is Eli Lilly's oral GLP-1, currently under FDA review with a decision expected mid-2026. Unlike semaglutide, orforglipron is a non-peptide small molecule that does not require empty-stomach dosing, which could significantly improve convenience. Triple agonists like retatrutide (targeting GLP-1, GIP, and glucagon receptors) are also in advanced clinical trials, and the medications available even a year from now will likely look quite different from what exists today.

Risks vs Benefits of GLP-1 Medications

The clinical evidence for GLP-1 medications is substantial. In the STEP 1 trial, participants taking semaglutide lost an average of 14.9 percent of their body weight over 68 weeks compared to 2.4 percent with placebo. For many people with obesity-related health conditions, that level of weight loss produces meaningful improvements in blood pressure, blood sugar, triglycerides and inflammatory markers. The SELECT trial showed a 20 percent reduction in major cardiovascular events (heart attack, stroke, cardiovascular death) in people with obesity taking semaglutide, even without diabetes. That was the first time a weight loss medication demonstrated cardiovascular protection in a large randomized trial. There is also growing evidence for benefits in non-alcoholic fatty liver disease and emerging research on kidney protection. Beyond the clinical data, many patients report a reduction in “food noise,” the constant mental preoccupation with food that makes sustained behavior change so difficult. For someone whose weight is driving serious health consequences, these benefits can be life-changing.

Dr. Christo Frangopoulos, MD, DipABLM, CPT from the Heal Nourish Grow advisory board specializes in lifestyle medicine. He points out it's important to consider what happens when patients discontinue GLP-1 medications. Studies show that patients who discontinued semaglutide regained an average of two-thirds of their prior weight loss within 12 months (STEP 1 extension trial) and in another meta-analysis published January 2026 in thebmj, found that on average, patients return to baseline weight within 1.5-1.7 years of stopping treatment.  This is important for two reasons; it shows that we need to include lifestyle and behavior change alongside treatment and some people may not think it's worth it if they have to do lifelong treatment.

That said, the decision to start a GLP-1 medication is not just about what happens while you are on it. It is equally important to understand what happens if you stop.

Natural Ways to Support GLP-1 Production

Whether you are on a GLP-1 medication or not, supporting your body's own GLP-1 production through diet and lifestyle is a smart strategy. This is where my whole-foods-first philosophy comes in. You cannot replicate pharmacological GLP-1 levels through diet alone, but you can meaningfully support the system your body already has in place.

Protein First

Protein is one of the strongest dietary stimulators of GLP-1 release. Multiple amino acids, including leucine, isoleucine, and lysine, are positively correlated with GLP-1 levels. This is one of many reasons I recommend a protein-first approach to every meal. Eggs, Greek yogurt, cottage cheese, fish, poultry, and high quality protein powders from brands like Equip (code HEALNOURISHGROW for 10% off) all support this goal. For a deeper dive, read my guide to how much protein women actually need.

Fermentable Fiber and Resistant Starch

When soluble fiber reaches your colon, gut bacteria ferment it into short-chain fatty acids (SCFAs) like butyrate, propionate, and acetate. These SCFAs bind to GPR43 receptors on the surface of L-cells and directly stimulate GLP-1 production. Research has also shown that dietary resistant starch increases both GLP-1 and PYY (peptide tyrosine-tyrosine) secretion in a sustained, day-long pattern through this same fermentation mechanism.

Great sources include oats, chia seeds, flaxseeds, legumes, cooled cooked potatoes (which form resistant starch), green bananas, and artichokes. For a full list of foods that support GLP-1 production, see my natural GLP-1 foods guide.

Fermented Foods and Gut Health

A healthy gut microbiome supports GLP-1 production through multiple pathways, including SCFA production and bile acid metabolism. Fermented foods like yogurt, kefir, sauerkraut, and kimchi provide beneficial bacteria that support this system. The connection between gut health and GLP-1 is one of the most active areas of current research.

Healthy Fats

Dietary fats, particularly long-chain unsaturated fatty acids, stimulate GLP-1 through bile acid signaling and direct receptor activation. Omega-3 rich foods like salmon, sardines, and walnuts, along with monounsaturated fats from olive oil and avocados, support this pathway.

Meal Sequencing Matters

Interestingly, the order in which you eat within a meal influences GLP-1 response. Eating protein and vegetables before carbohydrates produces a more robust GLP-1 response and better post-meal blood sugar control compared to eating carbohydrates first. Eating slowly and chewing thoroughly also enhances the GLP-1 response.

For those interested in natural GLP-1 supplements like berberine and probiotics, I have a research-based review in my GLP-1 supplements guide that separates the evidence from the hype.

Common Side Effects of GLP-1 Medications

GLP-1 medications are generally well tolerated, but side effects are real and worth understanding before starting treatment. The most common issues are gastrointestinal: nausea, constipation, diarrhea, and reduced appetite. These are often most pronounced when starting the medication or increasing the dose, and they tend to improve over time.

One of the more serious risks for people talking GLP-1 medications is they are twice as likely to have gallstones. In a systematic review and meta-analysis of 76 randomized clinical trials including 103,371 participants, GLP-1 receptor agonist use was associated with increased risk of gallbladder or biliary diseases overall. The risk was more than doubled in trials using GLP-1 medications for weight loss. For gallstones specifically, the increased risk was smaller but still significant. If you’re already at higher risk for gallstones be sure to alert your provider

For women specifically, there are additional considerations around hormonal changes during perimenopause and menopause, hair thinning (my collagen guide covers whether supplementation helps), and the facial volume changes sometimes called “Ozempic face.” I cover all of these in detail in my Ozempic side effects guide for women.

If you drink alcohol, you should also know that GLP-1 medications affect how your body processes it. Reduced tolerance and changes in liver metabolism are well documented. My Ozempic and alcohol guide covers what the research says.

The Compounding Landscape

An estimated 1.5 million Americans have used compounded versions of semaglutide and tirzepatide, primarily through telehealth platforms offering lower-cost alternatives during drug shortages. The regulatory landscape shifted significantly in early 2026 when the FDA escalated enforcement against mass-marketed compounded GLP-1 products, sending warning letters to 30 telehealth companies and referring some to the Department of Justice.

On March 9, 2026, Novo Nordisk and Hims reached a landmark settlement: Hims agreed to stop advertising compounded GLP-1s and instead offer branded FDA-approved products through its telehealth platform. The launch of the Wegovy pill at $149 per month has also reduced the cost barrier that drove many patients to compounding in the first place. For a complete breakdown of what this means for consumers, including safety data and transition options, read my compounded GLP-1 guide.

GLP-1 Beyond Weight Loss: Cardiovascular and Other Benefits

One of the most exciting developments in GLP-1 research is the growing evidence for benefits well beyond weight loss. A large meta-analysis covering 13 cardiovascular outcome trials and over 83,000 patients confirmed that GLP-1 receptor agonists significantly reduced major adverse cardiovascular events, all-cause mortality, cardiovascular mortality, and stroke risk.

The SUMMIT trial with tirzepatide showed a 38% reduction in the composite endpoint of cardiovascular death or worsening heart failure in patients with heart failure and obesity, which is one of the most significant treatment effects ever observed for that condition.

Emerging research also suggests potential benefits in areas including kidney protection, neuroprotection, fatty liver disease, and even addiction pathways. The GLP-1 receptor is expressed throughout the body, and scientists are only beginning to understand the full scope of what activating it can do.

The Bottom Line

GLP-1 is a naturally occurring hormone that plays a central role in appetite regulation, blood sugar control, and metabolic health. The medications built around this hormone have genuinely changed the landscape of weight management and chronic disease prevention. But the fundamentals have not changed: protein-first nutrition, regular strength training, and a whole-foods diet remain the foundation of lasting health, whether or not a GLP-1 medication is part of your plan.

If you are exploring GLP-1 medications or simply want to support your body's natural production, start with the basics. My GLP-1 diet plan provides a practical framework built on the same research covered in this article.

Explore the Full GLP-1 Guide

This article is the hub of my complete GLP-1 resource library. Here is every guide in the series:

• GLP-1 Diet Plan: What to Eat on Ozempic, Wegovy, Zepbound or Mounjaro
• Natural GLP-1 Foods: What to Eat to Boost GLP-1 Naturally
• GLP-1 and Muscle Loss: How to Protect Lean Mass on Ozempic
• GLP-1 Supplements: Do Natural GLP-1 Boosters Actually Work?
• GLP-1 Workout Plan: Strength Training While on Ozempic or Mounjaro
• Tirzepatide vs Semaglutide: Key Differences Explained
• Microdosing GLP-1: What the Research Says
• Wegovy vs Ozempic: Same Drug, Different Uses
• Ozempic Side Effects: What Women Need to Know
• Wegovy Pill: Everything You Need to Know About Oral Semaglutide
• Compounded GLP-1: What the FDA Crackdown Means for You
• GLP-1 Friendly Snacks: High Protein Ideas for Small Appetites
• Ozempic and Alcohol: What GLP-1 Users Should Know
• Protein Calculator for Women

This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or changing any medication.